You are here

Our science / Clinical Trials / Find a Trial / NCT00768833

Study Evaluating the Nasopharyngeal Carriage in Healthy Children

Back to Search Print Save as PDF Bookmark Trial

NCT00768833

Last updated on February 21, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Offenbach, , 63069 Germany
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy Subjects
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
3-4 months
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

Main inclusion criteria:

- Age at enrolment 3 to 4 month Main

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Malformation or injury of the nasopharynx

- Known or suspected immunodeficiency

- Relevant immunosuppression

- Use of antibiotics up to 10 days prior to study inclusion

NCT00768833
Pfizer
Completed
Study Evaluating the Nasopharyngeal Carriage in Healthy Children

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Healthy Subjects
Study Evaluating Enbrel Drug Levels in Healthy Male Chinese Subjects
NCT00705042
Males
18+
Years
Multiple Sites
Healthy Subjects
A Study To Assess The Safety, Tolerability, And Pharmacokinetics (PK) Of Multiple Doses Of PF-06865571 In Healthy, Including Overweight And Obese, Adult Subjects
NCT03230383
All Genders
18+
Years
Multiple Sites
Healthy Subjects
Study to Determine the Effect of a High-Fat Meal on the Relative Bioavailability and Pharmacokinetics of a Single Dose of Bosutinib Administered Orally to Healthy Subjects
NCT00721474
All Genders
18+
Years
Tacoma, Washington
Healthy Subjects, Osteoarthritis
Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses in Healthy
NCT00380900
All Genders
18+
Years
Philadelphia, Pennsylvania

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now